Beste apotheek van Nederland

Ruof J, Graf-Morgenstern M, Mnller M J. Quality of life in
patients with erection difficulties: Evaluation of a German
version of the "Quality of life measure for men with erection
difficulties" (QoL-Med). Aktuel Urol 2001;32(1):21-26.
Saad F, Grahl A S, Aversa A et al. Effects of testosterone on
erectile function: implications for the therapy of erectile
dysfunction. BJU Int 2007;99(5):988-992.
Saad F, Hoesl C E, Oettel M et al. Dehydroepiandrosterone
treatment in the aging male - What should the urologist know?.
Eur Urol 2005;48(5):724-733.
Sadeghi-Nejad H, Lim H, Long K et al. Assessment of the
efficacy of Viagra (sildenafil citrate) using the Erectile
Dysfunction Inventory of Treatment Satisfaction (EDITS). Urol
Int 2003;71(1):100-102.
Sadovsky R, Althof S. Men's sexual issues. Clinics in Family
Practice 2004;6(4 SPEC.ISS.):863-915.
Sahu M A, Ayyaz M, Chaudhry Z. Intracavernous injections of
papaverine and phentolamine for treatment of impotence. J Coll
Physicians Surg Pak 1997;7(3):102-104.
Saie D J, Sills E S. Hyperprolactinemia presenting with
encephalomalacia-associated seizure disorder and infertility: A
novel application for bromocriptine therapy in reproductive
endocrinology. Neuroendocrinol Lett 2005;26(5):533-537.
Salama N. Nocturnal electrobioimpedance volumetric
assessment in diabetic men with erectile dysfunction before and
after tadalafil intake. Int J Impot Res 2004;16(5):441-447.
Salonia A, Rigatti P, Montorsi F. Sildenafil in erectile
dysfunction: a critical review. Curr.Med Res Opin.
2003;19(4):241-262.
Salonia Andrea, Briganti Alberto, Montorsi Piero et al. Safety
and tolerability of oral erectile dysfunction treatments in the
elderly. [References]. Drugs and Aging 2005;22(4):323-338.
Sato Y, Horita H, Adachi H et al. Effect of oral administration
of prostaglandin E1 on erectile dysfunction. Br J Urol
1997;80(5):772-775.
Savoca G, Silvestre G, Belgrano E. Intracavernosal injection
therapy and surgical therapy in diabetic patients with erectile
dysfunction. [Review] [26 refs]. Diabetes, Nutrition &
Metabolism - Clinical & Experimental 2002;15(1):53-57.
Schanz S, Hauswirth U, Ulmer A et al. Prostaglandin E(1) ethyl
ester, a new agent for topical penile therapy. Int J Impot Res
2002;14(4):317-318.
Schimmer A D, Ali V, Stewart A K et al. Male sexual function
after autologous blood or marrow transplantation. Biology of
Blood & Marrow Transplantation 2001;7(5):279-283.
Schmid D M, Schurch B, Hauri D. Sildenafil in the treatment of
sexual dysfunction in spinal cord-injured male patients. Eur
Urol. 2000;38(2):184-193.
Schouman M, Lacroix P, Amer M. Suppression of
prostaglandin E1-induced pain by dilution of the drug
with lidocaine before intracavernous injection. Br J
Urol 1992;148(4):1266
Schroder F H, Whelan P, De Reijke T M et al.
Metastatic prostate cancer treated by flutamide versus
cyproterone acetate. Final analysis of the "European
Organization for Research and Treatment of Cancer"
(EORTC) Protocol 30892. Eur Urol 2004;45(4):457­
464.
Schulman C C, Shen W, Stothard D R et al. Integrated
analysis examining first-dose success, success by
dose, and maintenance of success among men taking
tadalafil for erectile dysfunction. Urology
2004;64(4):783-788.
Schultheiss D, Stief C G. Physiology and
pathophysiology of erection: Consequences for
present medical therapy of erectile dysfunction.
Andrologia 1999;31(SUPPL. 1):59-64.
Schultheiss D, Hiltl D M, Meschi M R et al. Pilot
study of the transdermal application of testosterone gel
to the penile skin for the treatment of
hypogonadotropic men with erectile dysfunction.
World J Urol 2000;18(6):431-435.
Seftel A D. From aspiration to achievement:
Assessment and noninvasive treatment of erectile
dysfunction in aging men. J Am Geriatr Soc
2005;53(1):119-130.
Segraves R T, Lee J, Stevenson R et al. Tadalafil for
treatment of erectile dysfunction in men on
antidepressants. J Clin Psychopharmacol
2007;27(1):62-66.
Seidman S N, Pesce V C, Roose S P. High-dose
sildenafil citrate for selective serotonin reuptake
inhibitor-associated ejaculatory delay: open clinical
trial. Hillside J Clin Psychiatry 2003;64(6):721-725.
Setter S M, Iltz J L, Fincham J E et al.
Phosphodiesterase 5 inhibitors for erectile
dysfunction. [Review] [75 refs]. Ann Pharmacother
2005;39(7-8):1286-1295.
Sexton W J, Benedict J F, Jarow J P. Comparison of
long-term outcomes of penile prostheses and
intracavernosal injection therapy.[see comment]. Br J
Urol 1998;159(3):811-815.
Shabbir M, Mikhailidis D M, Morgan R J. Erectile
dysfunction: an underdiagnosed condition associated
with multiple risk factors.[comment]. Current Medical
Research & Opinion 2004;20(5):603-606.
Shabsigh R. Testosterone therapy in erectile
dysfunction and hypogonadism. Br J Sex Med
2005;2(6):785-792.
D-119